Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

ICN to Acquire Roche Holding Product Rights


Wall Street Journal (06/24/97) P. B13

ICN Pharmaceuticals reports that it will acquire worldwide rights to seven products currently owned by Roche Holding as well as a Roche manufacturing facility in Puerto Rico and non- U.S. rights to two other products. Under the terms of the transaction, Roche will receive $15 million in cash and a 10 percent equity stake in ICN, valued at nearly $90 million. ICN said it expects the seven products, which are used to treat disorders of the central nervous system and skin cancer, to boost its North American sales by about $52 million. Proceeds will be used by the company to further develop certain pharmaceuticals of its own, including Virazole, a new therapy for hepatitis C. Related Stories: Financial Times (06/24) P. 23; Investor's Business Daily (04/24) P. A2


Copyright © 1997 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in June 24, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.